Mackay Shields LLC’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-60,931
Closed -$1.86M 1098
2021
Q1
$1.86M Sell
60,931
-41,713
-41% -$1.27M 0.01% 805
2020
Q4
$2.03M Sell
102,644
-18,700
-15% -$370K 0.01% 849
2020
Q3
$1.58M Buy
121,344
+50,200
+71% +$655K 0.01% 881
2020
Q2
$807K Buy
71,144
+15,000
+27% +$170K 0.01% 1088
2020
Q1
$803K Buy
56,144
+3,400
+6% +$48.6K 0.01% 1016
2019
Q4
$1.44M Sell
52,744
-4,500
-8% -$123K 0.01% 982
2019
Q3
$1.64M Sell
57,244
-3,200
-5% -$91.6K 0.01% 979
2019
Q2
$1.68M Buy
60,444
+39,013
+182% +$1.08M 0.01% 969
2019
Q1
$712K Buy
21,431
+700
+3% +$23.3K 0.01% 1094
2018
Q4
$602K Sell
20,731
-1,071
-5% -$31.1K ﹤0.01% 1096
2018
Q3
$1M Sell
21,802
-2,300
-10% -$106K 0.01% 877
2018
Q2
$901K Sell
24,102
-500
-2% -$18.7K 0.01% 982
2018
Q1
$727K Buy
+24,602
New +$727K ﹤0.01% 1059